title: A treatment for activated B-cell-like DLBCL?
authors.affiliation: Institute of Hematology "Seràgnoli", University of Bologna, Bologna 40138, Italy. Electronic address: pierluigi.zinzani@unibo.it.
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D010880:Piperidines; D011241:Prednisone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C571759:R-CHOP protocol; C551803:ibrutinib; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D000225:Adenine; D011241:Prednisone